BIRAC Grand Challenges India (GCI) is a central scheme by BIRAC that supports high-impact biotech innovations through thematic open calls.
The BIRAC Grand Challenges India (GCI) is a central government initiative managed by BIRAC. This scheme is designed to foster high-impact innovations within the biotechnology sector.
It operates through a series of thematic open calls, where each call functions as a distinct program, or cohort. These cohorts focus on specific domains within biotechnology, such as diagnostics, maternal health, or nutrition, and offer different funding tiers.
Programs running under the BIRAC Grand Challenges India (GCI) scheme include:
No programs under BIRAC Grand Challenges India (GCI) are open right now — see past cohorts below, or check back soon.
Recently closed — many schemes re-open each cycle, so these are worth tracking for the next cohort.
GCI-BIRAC Vaginal Health Formulation Innovation Grant supports transformative women's health innovation for Indian women of reproductive age with milestone-based funding up to ₹2.2Cr.
BIRAC GCI grants up to ₹2 crore for breakthrough screening & diagnostics innovations in TB, emerging pathogens and enteric disease.
Compare this scheme's programs against the wider funding landscape.